Public record of meeting, 6 February, 2023

Meeting of February 6 & 7, 2023,

Virtual Meeting 

Task Force Fellows

• Shez Kassam
• Ashraf Sefin

Task Force Alumni

• Stéphane Groulx
• Brett Thombs

PHAC

• Anne Brasset-Latulippe
• Casey Gray
• Chantelle Garritty
• Elyse Chaikalis
• Leila Esmaeilisaraji
• Gregory Traversy
• Heather Limburg
• Julie Wu
• Laure Tessier
• Maurica Maher
• Mandy Huang
• Melissa Subnath

JGH

• Daniela Cortinovis
• Théodora Lufitha

ERSC

• Julian Little
• David Moher
• Jennifer Pillay
• Lisa Hartling
• Lindsay Gaudet
• Melissa Brouwers
• Nicole Shaver
• Dria Bennett

Knowledge Translation

• Sharon Straus
• Danielle Kasperavicius
• Robyn Beckett
• Arthana Chandraraj
• Sarah Deshpande
• Mohamed Hassan
• Mame-Awa Lajante
• Vanja Grubac

Communications

• Kim Barnhardt

Regrets:

Henry Siu (TF), Sidra Cheema (KT), Chantal Plante (PHAC), Amanda Tzenov (Fellow)

MINUTES

Day 1

1. Welcome and Introductions

The Task Force held its February 2023 meeting online via videoconference. Dr. Klarenbach opened the meeting and Task Force members approved the agenda. Dr. Klarenbach provided some brief guidelines on the proceedings of the virtual meeting. Roundtable introductions were done, and Dr. Klarenbach welcomed the new staff of the Task Force.

The co-Chairs elects were officially presented to the Task Force. Additionally, the Task Force expressed their gratitude and appreciation to Drs Wilson and Grad for their time as the interim co-Chairs.

2. Knowledge Translation (KT) Update

Ms. Beckett, Mr. Grubac, Mr. Hassan, and Ms. Deshpande from the Knowledge Translation (KT) team provided updates on recent KT activities and initiatives. This update included information on recently published and upcoming guidelines, new and upcoming KT tools, dissemination activities, the Clinical Prevention Leaders (CPL) Network, the Task Force Public Advisors Network (TF-PAN) initiative, and the 2022 Annual Evaluation.

3. Tobacco – Adult

Mr. Traversy presented updates on the Tobacco guideline, including an overview of the Evidence to Decision (EtD) framework for e-cigarette interventions for smoking cessation. Additionally, Mr. Traversy is seeking TF approval of direction and strength of proposed recommendations.

4. Hypertension Update

Dr. Wilson and Ms. Shaver presented an overview of the protocol and the scope of the key questions (KQs), a project status update as well as the next steps.

5. Methods WG Update

Ms. Subnath presented a general update on methods activities as well as an update on manual, timelines, and critical path.

6. Verbal Updates on Guidelines (Part 1)

The guideline Working Group Chair provided a brief update for the following guideline: Cervical Cancer.

7. Topics

Ms. Limburg presented on the recent selection of new topics for 2023 and provided an update on confirmation methods and topics along with the prioritization and allocation of resources.

8. Depression – Adult

Dr. Gray presented the guideline results, the draft recommendations along with other elements such as a summary/reminder of criticisms on pregnancy post-partum (PPP) depression.

9. Depression – Adolescent / Children

Ms. Subnath presented on the evidence (or lack thereof) and considerations going into draft guideline.

10. Verbal Updates on Guideline (Part 2)

The guideline Working Group Chairs provided brief updates for the following guidelines: Fragility Fractures, Falls Prevention, and Prostate Cancer.

11. Next Steps and Adjournment

Drs Abou-Setta, Thériault and Klarenbach thanked everyone for attending the meeting and for their contributions to the Task Force. The February 2023 Task Force virtual meeting was adjourned.